Tradewinds Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Tradewinds Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$19K	–	667
2018 Q4	$19K	Sell	200 -100	-33%	-$13.1K	0.01%	290
2018 Q3	$52K	Hold	300	–	–	0.02%	211
2018 Q2	$42K	Hold	300	–	–	0.02%	236
2018 Q1	$34K	Buy	+300	New	+$37.7K	0.02%	246
2014 Q3	–	Sell	-25	Closed	-$3K	–	650
2014 Q2	$3K	Buy	+25	New	+$1.74K	﹤0.01%	517

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tradewinds Capital Management's GWPH Position: Q1 2019 in Review

Tradewinds Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 200 shares — an estimated $19K sold.

Tradewinds Capital Management first reported a position in GWPH in Q2 2014 and held it in 5 quarters. The position peaked at $52K in Q3 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

Tradewinds Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Tradewinds Capital Management sold 200 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $19K.
Tradewinds Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 5 quarters.
Tradewinds Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $52K in Q3 2018.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Tradewinds Capital Management's 13F filing for Q1 2019, filed 23 Apr 2019.